Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5 (Source: Ghana Medical Journal)
Source: Ghana Medical Journal - August 14, 2023 Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
This study highlights the importance of considering HFrEF and NAFLD when developing treatment plans for patients with these comorbidities. Further research is needed in patients with coexisting HFrEF and NAFLD, with an emphasis on novel therapies and the importance of a multidisciplinary approach for managing these complex comorbidities.PMID:37576545 | PMC:PMC10415861 | DOI:10.4330/wjc.v15.i7.328 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - August 14, 2023 Category: Cardiology Authors: Jose Arriola-Montenegro Renato Beas Renato Cerna-Viacava Andres Chaponan-Lavalle Karla Hernandez Randich Diego Chambergo-Michilot Herson Flores Sanga Pornthira Mutirangura Source Type: research
